PharVision Advisers’s Prologis PLD Stock Holding History

PharVision Advisers’s Portfolio PLD Stock Details PLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,728	Closed	-$305K	–	393
2025 Q1	$305K	Buy	+2,728	New	+$316K	0.42%	91

Other funds holding PLD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PharVision Advisers's PLD Position: Q2 2025 in Review

PharVision Advisers sold out of Prologis (PLD) in Q2 2025, closing a stake of 2,728 shares — an estimated $305K sold.

PharVision Advisers first reported a position in PLD in Q1 2025 and held it in 1 quarter. The position peaked at $305K in Q1 2025. 1,489 funds tracked by Wall St. Rank hold PLD as of Q2 2025.

PharVision Advisers reported no remaining Prologis position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 2,728 Prologis shares in Q2 2025, an estimated $305K.
PharVision Advisers first reported a position in Prologis in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Prologis position peaked at $305K in Q1 2025.
1,489 funds tracked by Wall St. Rank held Prologis as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.